Literature DB >> 16521484

Increased asymmetric pulvinar magnetic resonance imaging signals in Creutzfeldt-Jakob disease with florid plaques following a cadaveric dura mater graft.

Yoshinobu Wakisaka1, Naohiko Santa, Katsumi Doh-ura, Tetsuyuki Kitamoto, Setsuro Ibayashi, Mitsuo Iida, Toru Iwaki.   

Abstract

A 9-year-old Japanese girl received a cadaveric dura mater graft during surgery following a head injury with brain contusion. She continued to do well, but when she became 19-years-old, she gradually showed a violent character and was treated in a psychiatric hospital. Another 6 years later, 200 months after the procedure, she developed a progressive gait ataxia, which subsequently led to her death within 10 months of onset. An autopsy showed she had CJD. This patient represents an atypical case of dura-associated CJD (dCJD) with unusual clinicopathological features including the late occurrence of myoclonus, an absence of periodic synchronous discharges in the electroencephalogram, and the presence of widespread florid plaques. However, our detection of an asymmetrical increase in the MRI-derived images of pulvinar nuclei has not been previously observed in other atypical cases of dCJD. Because atypical dCJD cases share several clinicopathological features with those of vCJD, and because asymmetrical hyperintense signals in the pulvinar have been observed in some neuropathologically confirmed vCJD cases, we had some difficulty in a differential diagnosis between atypical dCJD and vCJD. This is the first atypical dCJD case showing a pulvinar high signal compared with all other basal ganglia on MRI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16521484     DOI: 10.1111/j.1440-1789.2006.00638.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  6 in total

1.  MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob disease.

Authors:  B Meissner; K Kallenberg; P Sanchez-Juan; S Ramljak; A Krasnianski; U Heinemann; S Eigenbrod; E Gelpi; B Barsic; H A Kretzschmar; W J Schulz-Schaeffer; M Knauth; I Zerr
Journal:  J Neurol       Date:  2009-01-23       Impact factor: 4.849

Review 2.  Neuroimaging findings in human prion disease.

Authors:  R G Macfarlane; S J Wroe; J Collinge; T A Yousry; H R Jäger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-29       Impact factor: 10.154

3.  Iatrogenic Creutzfeldt-Jakob disease, final assessment.

Authors:  Paul Brown; Jean-Philippe Brandel; Takeshi Sato; Yosikazu Nakamura; Jan MacKenzie; Robert G Will; Anna Ladogana; Maurizio Pocchiari; Ellen W Leschek; Lawrence B Schonberger
Journal:  Emerg Infect Dis       Date:  2012-06       Impact factor: 6.883

4.  Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone.

Authors:  Ignazio Cali; Cathleen J Miller; Joseph E Parisi; Michael D Geschwind; Pierluigi Gambetti; Lawrence B Schonberger
Journal:  Acta Neuropathol Commun       Date:  2015-06-25       Impact factor: 7.801

5.  Characterization of Sporadic Creutzfeldt-Jakob Disease and History of Neurosurgery to Identify Potential Iatrogenic Cases.

Authors:  Tsuyoshi Hamaguchi; Kenji Sakai; Atsushi Kobayashi; Tetsuyuki Kitamoto; Ryusuke Ae; Yosikazu Nakamura; Nobuo Sanjo; Kimihito Arai; Mizuho Koide; Fumiaki Katada; Masafumi Harada; Hiroyuki Murai; Shigeo Murayama; Tadashi Tsukamoto; Hidehiro Mizusawa; Masahito Yamada
Journal:  Emerg Infect Dis       Date:  2020-06       Impact factor: 6.883

6.  Enhanced detection of diffusion reductions in Creutzfeldt-Jakob disease at a higher B factor.

Authors:  H Lee; C Hoffman; P B Kingsley; A Degnan; O Cohen; I Prohovnik
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-12       Impact factor: 4.966

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.